Skip to main content
Clinical Trials/NCT06500351
NCT06500351RecruitingNot Applicable

Renalase(rs10887800) Genotyping & Leucocytes Telomere Length in Patients With Postpartum Hypertension.

Sohag University1 site in 1 country90 target enrollmentStarted: June 25, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
90
Locations
1
Primary Endpoint
Renalase(rs10887800) Genotyping

Study Overview

Brief Summary

This is an observertional study aimed at Study the association between Renalase(rs10887800) Genotyping & Leucocytes telomere length in patients with postpartum hypertension whether new onset( denovo) or persistent following pregnancy complicated by hypertension.

Study Design

Study Type
Observational
Observational Model
Case Control
Time Perspective
Cross Sectional

Eligibility Criteria

Ages
18 Years to 45 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients who are18 years or above, and have a diagnosis of postpartum hypertension(regardless of where they received their antenatal care) attended to Sohag university hospitals

Exclusion Criteria

  • All pregnant women with medical disorders in pregnancy other than Hypertensive disorders during pregnancy (e.g., sickle cell disease, heart disease, kidney and other connective tissues disorders) will be excluded from the study. Also we excluded measurements taken during scheduled or unscheduled surgical encounters given potential for interaction with anesthetic agents

Outcomes

Primary Outcomes

Renalase(rs10887800) Genotyping

Time Frame: 1 year

The presence of gene polymorphism whether homogenetic or heterogenetic

Secondary Outcomes

  • Leucocytes telomere length(1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Amera Morad Foad

Assistant Professor of Medical Biochemistry

Sohag University

Study Sites (1)

Loading locations...

Similar Trials